192 related articles for article (PubMed ID: 35500377)
21. A novel LMNA nonsense mutation causes two distinct phenotypes of cardiomyopathy with high risk of sudden cardiac death in a large five-generation family.
Glöcklhofer CR; Steinfurt J; Franke G; Hoppmann A; Glantschnig T; Perez-Feliz S; Alter S; Fischer J; Brunner M; Rainer PP; Köttgen A; Bode C; Odening KE
Europace; 2018 Dec; 20(12):2003-2013. PubMed ID: 29947763
[TBL] [Abstract][Full Text] [Related]
22. An alpha-helix variant p.Arg156Pro in LMNA as a cause of hereditary dilated cardiomyopathy: genetics and bioinfomatics exploration.
Chang L; Huang R; Chen J; Li G; Shi G; Xu B; Wang L
BMC Med Genomics; 2023 Oct; 16(1):229. PubMed ID: 37784143
[TBL] [Abstract][Full Text] [Related]
23. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
24. Lamin A/C mutations in dilated cardiomyopathy.
Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
[TBL] [Abstract][Full Text] [Related]
25. Expression of Lmna-R225X nonsense mutation results in dilated cardiomyopathy and conduction disorders (DCM-CD) in mice: Impact of exercise training.
Cai ZJ; Lee YK; Lau YM; Ho JC; Lai WH; Wong NL; Huang D; Hai JJ; Ng KM; Tse HF; Siu CW
Int J Cardiol; 2020 Jan; 298():85-92. PubMed ID: 31668660
[TBL] [Abstract][Full Text] [Related]
26. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
27. Genotype Complements the Phenotype: Identification of the Pathogenicity of an LMNA Splice Variant by Nanopore Long-Read Sequencing in a Large DCM Family.
Sedaghat-Hamedani F; Rebs S; Kayvanpour E; Zhu C; Amr A; Müller M; Haas J; Wu J; Steinmetz LM; Ehlermann P; Streckfuss-Bömeke K; Frey N; Meder B
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293084
[TBL] [Abstract][Full Text] [Related]
28. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
[TBL] [Abstract][Full Text] [Related]
29.
Kato K; Ohno S; Sonoda K; Fukuyama M; Makiyama T; Ozawa T; Horie M
Circ Genom Precis Med; 2020 Oct; 13(5):435-443. PubMed ID: 32818388
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a novel human iPSC line (YCMi003-A) from a patient with dilated cardiomyopathy carrying genetic variant LMNA p.Asp364His.
Oh J; Lee SH; Choi J; Choi JR; Kim S; Cha YJ; Choi HK; Won D; Yoon HG; Park SW; Kang SM; Lee ST; Lee SH
Stem Cell Res; 2021 Oct; 56():102508. PubMed ID: 34438160
[TBL] [Abstract][Full Text] [Related]
31. Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy.
Izquierdo I; Rosa I; Bravo SB; Guitián E; Pérez-Serra A; Campuzano O; Brugada R; Mangas A; García Á; Toro R
J Proteomics; 2016 Oct; 148():75-84. PubMed ID: 27457270
[TBL] [Abstract][Full Text] [Related]
32. LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.
Saj M; Bilinska ZT; Tarnowska A; Sioma A; Bolongo P; Sobieszczanska-Malek M; Michalak E; Golen D; Mazurkiewicz L; Malek L; Walczak E; Fidzianska A; Grzybowski J; Przybylski A; Zielinski T; Korewicki J; Tesson F; Ploski R
BMC Med Genet; 2013 May; 14():55. PubMed ID: 23702046
[TBL] [Abstract][Full Text] [Related]
33. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
[TBL] [Abstract][Full Text] [Related]
34. The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice.
Yang L; Sun J; Chen Z; Liu L; Sun Y; Lin J; Hu X; Zhao M; Ma Y; Lu D; Li Y; Guo Y; Dong E
Int J Cardiol; 2022 Sep; 363():149-158. PubMed ID: 35714719
[TBL] [Abstract][Full Text] [Related]
35. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.
Jansweijer JA; Nieuwhof K; Russo F; Hoorntje ET; Jongbloed JD; Lekanne Deprez RH; Postma AV; Bronk M; van Rijsingen IA; de Haij S; Biagini E; van Haelst PL; van Wijngaarden J; van den Berg MP; Wilde AA; Mannens MM; de Boer RA; van Spaendonck-Zwarts KY; van Tintelen JP; Pinto YM
Eur J Heart Fail; 2017 Apr; 19(4):512-521. PubMed ID: 27813223
[TBL] [Abstract][Full Text] [Related]
36. A novel mutation of the LMNA gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females.
Chen W; Huo J; Ma A; Bai L; Liu P
Mol Cell Biochem; 2013 Oct; 382(1-2):307-11. PubMed ID: 23793583
[TBL] [Abstract][Full Text] [Related]
37. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
[TBL] [Abstract][Full Text] [Related]
38. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
[TBL] [Abstract][Full Text] [Related]
39. An LMNA synonymous variant associated with severe dilated cardiomyopathy: Case report.
Gao S; Mumme-Monheit A; Chen SN; Spector EB; Slavov D; Baralle FE; Bristow MR; Mestroni L; Taylor MRG;
Am J Med Genet A; 2022 Feb; 188(2):600-605. PubMed ID: 34652067
[TBL] [Abstract][Full Text] [Related]
40. Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty
MacRae CA; Taylor MR; Mestroni L; Moses J; Ashley EA; Wheeler MT; Lakdawala NK; Hershberger RE; Sandor V; Saunders ME; Oliver C; Lee PA; Judge DP
Future Cardiol; 2023 Feb; 19(2):55-63. PubMed ID: 36718638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
